Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL3276907

N.O=C(O)C(CO)Nc1ccccc1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MME P08473 1/20 0.44
CA12 O43570 2/20 0.42
CA9 Q16790 2/20 0.42
GAA P10253 3/20 0.41
POLB P06746 1/20 0.41
CA2 P00918 4/20 0.41
CA1 P00915 3/20 0.41
CA14 Q9ULX7 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
TSHR P16473 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
TP53 P04637 1/20 0.40
EPHX1 P07099 1/20 0.40
EPHX2 P34913 1/20 0.40
CDK9 P50750 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
PPARG P37231 1/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL344919 0.98 MME (0.45) MMECA12CA9GAAPOLB
SCHEMBL344918 0.98 MME (0.45) MMECA12CA9GAAPOLB
SCHEMBL3488827 0.98 MME (0.45) MMECA12CA9GAAPOLB
SCHEMBL28770012 0.96 MME (0.44) MMECA12CA9GAAPOLB
Methane SCHEMBL9693759 0.96 MME (0.44) MMECA12CA9GAAPOLB
Water SCHEMBL4595531 0.96 MME (0.44) MMECA12CA9GAAPOLB
Water SCHEMBL4595529 0.96 MME (0.44) MMECA12CA9GAAPOLB
Cadaverine Tartrate SCHEMBL30645547 0.91 MME (0.41) MMECA12CA9GAAPOLB
Cadaverine Tartrate SCHEMBL27541361 0.91 MME (0.41) MMECA12CA9GAAPOLB
Glycine SCHEMBL9680814 0.89 GAA (0.41) MMECA12CA9GAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687435-B2 Benzoyl-substituted phenylalanineamides BASF AKTIENGESELLSCHAFT (DE) 2010-03-30 US disclosed
US-20070142230-A1 Benzoyl-substituted phenylalanineamides BASF AKTIENGESELLSCHAFT (DE) 2007-06-21 US disclosed
US-20070060480-A1 Heteroaroyl-substituted phenylalanineamides BASF AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
CN-1898213-A Heteroaroyl-substituted phenylalanineamides with herbicidal action BASF AG (DE) 2007-01-17 CN disclosed
CN-1894202-A Benzoyl-substituted phenylalanine amides BASF AG (DE) 2007-01-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142230-A1 Benzoyl-substituted phenylalanineamides PAH, TYR, BCAT2 MME 606/4885CA12 4112/4885CA9 3682/4885
US-20070060480-A1 Heteroaroyl-substituted phenylalanineamides PAH, PM20D2, FARSA MME 1689/4885CA12 4205/4885CA9 3637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.